Complementary Alternative Medicine for Reconstitution of CD4 count and Quality of Life in HIV-Infected Patients with Advanced Disease

Completed

• Conditions: HIV-Infected Patients with Advanced Disease under HAART; Infections and Infestations; Human immunodeficiency virus [HIV] disease

• Registration Number: ISRCTN03831044
• Lead Sponsor: Hospital San Juan de Dios (Chile)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-07-08
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

1. Any adult patient infected with HIV who has a naïve CD4 count < 200 cell/mL and who, despite > 48 weeks of HAART, keep CD4 < 250 cell/mL
2. Adherent to HAART and to the controls with the physician in charge of treatment of the HIV-condition
3. Patients who modify their HAART regimens are not excluded if plasma HIV-1 RNA levels, remain < 80 copies/m

Exclusion Criteria

Patients who use hydroxyurea, IL-2, IFN-a, or the combination of tenofovir and didanosine, which are known to affect CD4 count increases

Study & Design

• Study Type: Interventional
• Study Design: Not specified